NASDAQ:ILMN - Illumina Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$266.22 -4.61 (-1.70 %)
(As of 05/28/2018 01:25 AM ET)
Previous Close$266.22
Today's Range$264.50 - $271.35
52-Week Range$167.98 - $273.93
Volume679,138 shs
Average Volume679,511 shs
Market Capitalization$39.13 billion
P/E Ratio66.56
Dividend YieldN/A
Beta0.86

About Illumina (NASDAQ:ILMN)

Illumina logoIllumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs. It offers sequencing by synthesis technology that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow the detection of known genetic markers on a single array. The company also provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and noninvasive prenatal testing, as well as products support services. It serves genomic research centers, academic institutions, government laboratories, and hospitals; and pharmaceutical, biotechnology, agrigenomics, and commercial molecular diagnostic laboratories, as well as consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. It operates in North America, Europe, Latin America, the Asia-Pacific region, the Middle East, and South Africa. The company has a strategic partnership with Loxo Oncology, Inc. to develop and commercialize a multi-gene panel for broad tumor profiling; and strategic collaboration with Bristol-Myers Squibb Company. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

Receive ILMN News and Ratings via Email

Sign-up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorMedical
SymbolNASDAQ:ILMN
CUSIP45232710
Phone858-202-4500

Debt

Debt-to-Equity Ratio0.23
Current Ratio2.71
Quick Ratio2.41

Price-To-Earnings

Trailing P/E Ratio66.56
Forward P/E Ratio54.78
P/E Growth2.74

Sales & Book Value

Annual Sales$2.75 billion
Price / Sales14.22
Cash Flow$5.3223 per share
Price / Cash50.02
Book Value$20.91 per share
Price / Book12.73

Profitability

EPS (Most Recent Fiscal Year)$4.00
Net Income$726 million
Net Margins19.31%
Return on Equity24.93%
Return on Assets13.72%

Miscellaneous

Employees6,200
Outstanding Shares147,000,000

Illumina (NASDAQ:ILMN) Frequently Asked Questions

What is Illumina's stock symbol?

Illumina trades on the NASDAQ under the ticker symbol "ILMN."

How were Illumina's earnings last quarter?

Illumina (NASDAQ:ILMN) posted its quarterly earnings results on Tuesday, April, 24th. The life sciences company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.02 by $0.43. The life sciences company had revenue of $782 million for the quarter, compared to analysts' expectations of $744.30 million. Illumina had a net margin of 19.31% and a return on equity of 24.93%. Illumina's revenue was up 30.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.64 EPS. View Illumina's Earnings History.

When is Illumina's next earnings date?

Illumina is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Illumina.

What guidance has Illumina issued on next quarter's earnings?

Illumina updated its FY18 earnings guidance on Tuesday, April, 24th. The company provided earnings per share (EPS) guidance of $4.75-4.85 for the period, compared to the Thomson Reuters consensus estimate of $4.59. The company issued revenue guidance of +15-16% to ~$3.16-3.19 billion, compared to the consensus revenue estimate of $3.14 billion.

What price target have analysts set for ILMN?

19 analysts have issued 12 month target prices for Illumina's stock. Their forecasts range from $180.00 to $277.00. On average, they expect Illumina's share price to reach $252.0625 in the next twelve months. View Analyst Ratings for Illumina.

What are Wall Street analysts saying about Illumina stock?

Here are some recent quotes from research analysts about Illumina stock:
  • 1. According to Zacks Investment Research, "In the last three months, Illumina outperformed its industry. The company’s recent strategic collaborations are expected to expand its product portfolio. This apart an improving margin scenario should also instill confidence on the stock. Currently, Illumina is focusing on product innovation through research and development as well, which is evident from the launch of iSeq 100 Sequencing System recently. Post a promising fourth-quarter show, we expect Illumina to maintain its growth momentum on continued uptake of sequencing consumables, instruments and microarray portfolios. On the flip side, the company is operating in a tough competitive landscape which is a concern. Further, the stock looks a bit overvalued at the moment." (4/16/2018)
  • 2. Canaccord Genuity analysts commented, "Shipments to China grew +16% and we believe China is likely to be a double-digit grower for ILMN over the next several years, driven by the Chinese Precision Medicine Initiative," (8/7/2017)

Who are some of Illumina's key competitors?

Who are Illumina's key executives?

Illumina's management team includes the folowing people:
  • Mr. Jay T. Flatley, Exec. Chairman (Age 65)
  • Mr. Francis A. deSouza, CEO, Pres & Director (Age 47)
  • Mr. Sam A. Samad, CFO & Sr. VP (Age 48)
  • Mr. Omead Ostadan, Exec. VP of Operations and Products (Age 46)
  • Mr. Marc A. Stapley, Exec. VP of Strategy & Corp. Devel. (Age 48)

Has Illumina been receiving favorable news coverage?

News coverage about ILMN stock has been trending somewhat positive on Monday, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Illumina earned a news sentiment score of 0.11 on Accern's scale. They also gave media headlines about the life sciences company an impact score of 46.00 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Who are Illumina's major shareholders?

Illumina's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Baillie Gifford & Co. (12.02%), Edgewood Management LLC (3.51%), Winslow Capital Management LLC (0.64%), Prudential Financial Inc. (0.52%), American Century Companies Inc. (0.52%) and Legal & General Group Plc (0.45%). Company insiders that own Illumina stock include A Blaine Bowman, Charles Dadswell, Christian O Henry, Daniel Bradbury, Frances Arnold, Francis A Desouza, Jay T Flatley, Karin Eastham, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Oene Mark Van, Omead Ostadan, Robert S Epstein and Roy A Whitfield. View Institutional Ownership Trends for Illumina.

Which institutional investors are selling Illumina stock?

ILMN stock was sold by a variety of institutional investors in the last quarter, including Winslow Capital Management LLC, Baillie Gifford & Co., Sei Investments Co., Swiss National Bank, Reynders McVeigh Capital Management LLC, Van ECK Associates Corp, Guggenheim Capital LLC and New York State Common Retirement Fund. Company insiders that have sold Illumina company stock in the last year include A Blaine Bowman, Charles Dadswell, Frances Arnold, Francis A Desouza, Jay T Flatley, Karin Eastham, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Oene Mark Van, Omead Ostadan and Robert S Epstein. View Insider Buying and Selling for Illumina.

Which institutional investors are buying Illumina stock?

ILMN stock was acquired by a variety of institutional investors in the last quarter, including Federated Investors Inc. PA, Prudential Financial Inc., Rockefeller Capital Management L.P., Summit Trail Advisors LLC, Millennium Management LLC, Lord Abbett & CO. LLC, American Century Companies Inc. and Scout Investments Inc.. View Insider Buying and Selling for Illumina.

How do I buy shares of Illumina?

Shares of ILMN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Illumina's stock price today?

One share of ILMN stock can currently be purchased for approximately $266.22.

How big of a company is Illumina?

Illumina has a market capitalization of $39.13 billion and generates $2.75 billion in revenue each year. The life sciences company earns $726 million in net income (profit) each year or $4.00 on an earnings per share basis. Illumina employs 6,200 workers across the globe.

How can I contact Illumina?

Illumina's mailing address is 5200 ILLUMINA WAY, SAN DIEGO CA, 92122. The life sciences company can be reached via phone at 858-202-4500 or via email at [email protected]


MarketBeat Community Rating for Illumina (ILMN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  744 (Vote Outperform)
Underperform Votes:  729 (Vote Underperform)
Total Votes:  1,473
MarketBeat's community ratings are surveys of what our community members think about Illumina and other stocks. Vote "Outperform" if you believe ILMN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ILMN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Illumina (NASDAQ:ILMN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
19 Wall Street analysts have issued ratings and price targets for Illumina in the last 12 months. Their average twelve-month price target is $252.0625, suggesting that the stock has a possible downside of 5.32%. The high price target for ILMN is $277.00 and the low price target for ILMN is $180.00. There are currently 1 sell rating, 4 hold ratings and 14 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.682.632.602.52
Ratings Breakdown: 1 Sell Rating(s)
4 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $252.0625$252.0625$242.1765$198.5263
Price Target Upside: 5.32% downside8.16% upside9.99% upside3.09% downside

Illumina (NASDAQ:ILMN) Consensus Price Target History

Price Target History for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ:ILMN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/7/2018BarclaysUpgradeEqual Weight ➝ Overweight$235.00HighView Rating Details
4/25/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$170.00 ➝ $180.00MediumView Rating Details
4/25/2018BTIG ResearchReiterated RatingHoldHighView Rating Details
4/25/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$261.00 ➝ $271.00HighView Rating Details
2/5/2018CitigroupUpgradeNeutral ➝ Buy$260.00 ➝ $275.00HighView Rating Details
1/31/2018Leerink SwannBoost Price TargetOutperform ➝ Outperform$250.00 ➝ $276.00HighView Rating Details
1/31/2018Canaccord GenuityReiterated RatingBuy$255.00 ➝ $265.00HighView Rating Details
1/31/2018First AnalysisUpgradeEqual Weight ➝ Overweight$277.00HighView Rating Details
1/22/2018CowenBoost Price TargetOutperform$250.00 ➝ $275.00LowView Rating Details
1/16/2018Deutsche BankSet Price TargetBuy$275.00MediumView Rating Details
1/9/2018Wells Fargo & CoReiterated RatingOutperform ➝ Positive$250.00 ➝ $260.00HighView Rating Details
1/9/2018Piper Jaffray CompaniesReiterated RatingBuy$269.00N/AView Rating Details
1/5/2018William BlairDowngradeOutperform ➝ Market PerformMediumView Rating Details
1/3/2018Evercore ISIInitiated CoverageOutperform$250.00LowView Rating Details
10/25/2017Bank of AmericaBoost Price TargetBuy$215.00 ➝ $240.00N/AView Rating Details
10/23/2017Janney Montgomery ScottUpgradeSell ➝ NeutralN/AView Rating Details
9/26/2017Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$200.00LowView Rating Details
9/13/2017ArgusBoost Price TargetBuy$205.00 ➝ $235.00LowView Rating Details
8/2/2017JPMorgan Chase & Co.Reiterated RatingOverweight$250.00HighView Rating Details
4/26/2017Cantor FitzgeraldBoost Price TargetNeutral ➝ Neutral$155.00 ➝ $170.00HighView Rating Details
2/1/2017UBSBoost Price TargetBuy$180.00 ➝ $185.00N/AView Rating Details
1/6/2017CL KingUpgradeNeutral ➝ BuyN/AView Rating Details
7/27/2016MizuhoBoost Price TargetNeutral$138.00 ➝ $148.00N/AView Rating Details
(Data available from 5/28/2016 forward)

Earnings

Illumina (NASDAQ:ILMN) Earnings History and Estimates Chart

Earnings by Quarter for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ:ILMN) Earnings Estimates

2018 EPS Consensus Estimate: $4.41
2019 EPS Consensus Estimate: $5.48
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$0.88$1.09$1.00
Q2 20184$1.07$1.15$1.10
Q3 20184$1.10$1.24$1.14
Q4 20184$1.16$1.17$1.17
Q1 20194$1.19$1.64$1.37
Q2 20193$1.20$1.36$1.27
Q3 20193$1.35$1.45$1.41
Q4 20193$1.36$1.53$1.43

Illumina (NASDAQ ILMN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/30/2018$1.11N/AView Earnings Details
4/24/2018Q1 2018$1.02$1.45$744.30 million$782.00 millionViewN/AView Earnings Details
1/30/2018Q4 2017$1.22$1.44$752.04 million$778.00 millionViewListenView Earnings Details
10/24/2017Q3 2017$0.99$1.11$692.77 million$714.00 millionViewN/AView Earnings Details
8/1/2017Q2 2017$0.68$0.82$642.38 million$662.00 millionViewListenView Earnings Details
4/25/2017Q1 2017$0.64$0.64$590.51 million$598.00 millionViewN/AView Earnings Details
1/31/2017Q416$0.82$0.85$612.50 million$619.00 millionViewListenView Earnings Details
11/1/2016Q316$0.87$0.97$628.06 million$607.00 millionViewListenView Earnings Details
7/26/2016Q2$0.73$0.86$31.91 million$600.00 millionViewListenView Earnings Details
5/3/2016Q1$0.74$0.71$596.33 million$572.00 millionViewListenView Earnings Details
2/2/2016Q415$0.82$0.81$576.39 million$591.50 millionViewListenView Earnings Details
10/20/2015Q315$0.79$0.80$568.60 million$550.00 millionViewListenView Earnings Details
7/21/2015Q215$0.77$0.80$541.05 million$539.00 millionViewListenView Earnings Details
4/21/2015Q115$0.72$0.91$524.35 million$539.00 millionViewListenView Earnings Details
1/27/2015Q414$0.78$0.87$503.83 million$512.00 millionViewListenView Earnings Details
10/20/2014Q314$0.56$0.77$451.20 million$481.00 millionViewListenView Earnings Details
7/23/2014Q214$0.51$0.57$426.50 million$448.00 millionViewListenView Earnings Details
4/22/2014Q114$0.44$0.53$391.50 million$421.00 millionViewListenView Earnings Details
1/28/2014Q413$0.44$0.45$382.06 million$387.00 millionViewListenView Earnings Details
10/21/2013Q313$0.40$0.45$343.42 million$357.00 millionViewListenView Earnings Details
7/23/2013Q2 2013$0.40$0.43$331.77 million$346.09 millionViewListenView Earnings Details
4/22/2013Q1 2013$0.39$0.46$310.64 million$330.96 millionViewListenView Earnings Details
1/28/2013Q4 2012$0.41$0.42$303.13 million$309.30 millionViewListenView Earnings Details
10/23/2012$0.39$0.41ViewN/AView Earnings Details
7/24/2012$0.36$0.40ViewN/AView Earnings Details
4/23/2012$0.32$0.36ViewN/AView Earnings Details
2/7/2012$0.30$0.35ViewN/AView Earnings Details
10/25/2011$0.23$0.22ViewN/AView Earnings Details
7/26/2011Q2 2011$0.36$0.38ViewN/AView Earnings Details
4/26/2011$0.31$0.35ViewN/AView Earnings Details
2/8/2011$0.29$0.29ViewN/AView Earnings Details
10/26/2010Q3 2010$0.24$0.30ViewN/AView Earnings Details
7/27/2010Q2 2010$0.23$0.26ViewN/AView Earnings Details
4/28/2010Q1 2010$0.19$0.21ViewN/AView Earnings Details
2/4/2010Q4 2009$0.19$0.20ViewN/AView Earnings Details
10/27/2009Q3 2009$0.20$0.17ViewN/AView Earnings Details
7/21/2009Q2 2009$0.18$0.18ViewN/AView Earnings Details
4/21/2009Q1 2009$0.19$0.19ViewN/AView Earnings Details
2/3/2009Q4 2008$0.17$0.24ViewN/AView Earnings Details
10/21/2008Q3 2008$0.17$0.17ViewN/AView Earnings Details
7/22/2008Q2 2008$0.14$0.15ViewN/AView Earnings Details
4/22/2008Q1 2008$0.12$0.12ViewN/AView Earnings Details
2/4/2008Q4 2007$0.12$0.15ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Illumina (NASDAQ:ILMN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Illumina (NASDAQ ILMN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.54%
Institutional Ownership Percentage: 90.75%
Insider Trading History for Illumina (NASDAQ:ILMN)
Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ ILMN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/21/2018Karin EasthamDirectorSell1,000$269.80$269,800.0013,088View SEC Filing  
5/16/2018Mostafa RonaghiSVPSell10,000$267.71$2,677,100.0080,996View SEC Filing  
5/14/2018Francis A DesouzaCEOSell2,100$268.63$564,123.0087,371View SEC Filing  
5/14/2018Jay T. FlatleyDirectorSell1,460$268.00$391,280.00View SEC Filing  
5/2/2018Omead OstadanEVPSell1,314$242.60$318,776.4027,153View SEC Filing  
5/1/2018A Blaine BowmanDirectorSell3,000$241.45$724,350.0018,668View SEC Filing  
4/12/2018Oene Mark VanSVPSell1,400$238.48$333,872.0012,217View SEC Filing  
4/3/2018Charles DadswellSVPSell116$230.91$26,785.567,875View SEC Filing  
4/2/2018A Blaine BowmanDirectorSell3,000$230.13$690,390.0019,868View SEC Filing  
3/15/2018Frances ArnoldDirectorSell250$252.26$63,065.0010,189View SEC Filing  
3/8/2018Frances ArnoldDirectorSell250$241.50$60,375.0010,439View SEC Filing  
3/5/2018Charles DadswellSVPSell145$227.17$32,939.657,991View SEC Filing  
3/5/2018Karin EasthamDirectorSell2,000$229.37$458,740.0015,288View SEC Filing  
3/2/2018Omead OstadanEVPSell1,329$222.66$295,915.1429,392View SEC Filing  
2/28/2018Robert S EpsteinDirectorSell250$231.25$57,812.507,088View SEC Filing  
2/16/2018Oene Mark VanSVPSell1,408$228.85$322,220.8015,760View SEC Filing  
2/6/2018Marc StapleyEVPSell2,000$216.87$433,740.0027,952View SEC Filing  
2/5/2018Charles DadswellSVPSell1,610$221.45$356,534.505,581View SEC Filing  
2/1/2018A Blaine BowmanDirectorSell3,000$230.82$692,460.0019,868View SEC Filing  
1/29/2018Robert S EpsteinDirectorSell1,250$244.18$305,225.008,588View SEC Filing  
1/17/2018Marc StapleyEVPSell2,000$242.33$484,660.0029,815View SEC Filing  
1/16/2018Jay T FlatleyDirectorSell15,000$243.72$3,655,800.00449,201View SEC Filing  
1/3/2018Charles DadswellSVPSell145$224.50$32,552.507,411View SEC Filing  
1/2/2018Jay T FlatleyDirectorSell20,000$223.40$4,468,000.00463,436View SEC Filing  
12/29/2017Robert S EpsteinDirectorSell1,250$217.38$271,725.00View SEC Filing  
12/29/2017Robert S EpsteinDirectorSell1,250$217.38$271,725.008,838View SEC Filing  
12/19/2017Jay T FlatleyDirectorSell20,000$215.48$4,309,600.00480,476View SEC Filing  
12/5/2017Jay T FlatleyDirectorSell20,000$212.55$4,251,000.00505,980View SEC Filing  
12/4/2017Charles DadswellSVPSell145$225.33$32,672.856,388View SEC Filing  
12/4/2017Marc StapleyEVPSell2,000$219.88$439,760.0029,198View SEC Filing  
12/1/2017Omead OstadanEVPSell3,540$226.91$803,261.4026,827View SEC Filing  
12/1/2017Robert S EpsteinDirectorSell1,250$226.55$283,187.509,088View SEC Filing  
11/21/2017Jay T FlatleyDirectorSell20,000$211.35$4,227,000.00531,717View SEC Filing  
11/15/2017Marc StapleyEVPSell2,000$205.48$410,960.0030,370View SEC Filing  
11/15/2017Oene Mark VanSVPSell1,250$207.76$259,700.0011,691View SEC Filing  
11/13/2017Oene Mark VanSVPSell1,232$207.78$255,984.9611,691View SEC Filing  
11/7/2017Jay T FlatleyDirectorSell20,000$210.59$4,211,800.00536,717View SEC Filing  
11/3/2017Charles DadswellSVPSell1,609$207.88$334,478.927,217View SEC Filing  
10/26/2017Marc StapleyEVPSell2,000$206.88$413,760.0034,579View SEC Filing  
10/24/2017Jay T FlatleyDirectorSell20,000$210.43$4,208,600.00539,176View SEC Filing  
10/12/2017Oene Mark VanSVPSell1,250$207.21$259,012.50View SEC Filing  
10/10/2017Jay T FlatleyDirectorSell20,000$203.27$4,065,400.00View SEC Filing  
10/3/2017Charles DadswellSVPSell145$202.23$29,323.35View SEC Filing  
9/26/2017Jay T FlatleyDirectorSell20,000$200.16$4,003,200.00539,176View SEC Filing  
9/12/2017Jay T FlatleyDirectorSell20,000$211.11$4,222,200.00539,176View SEC Filing  
9/12/2017Oene Mark VanSVPSell9,729$211.33$2,056,029.5724,908View SEC Filing  
9/7/2017Mostafa RonaghiSVPSell20,000$210.00$4,200,000.0086,725View SEC Filing  
9/5/2017Charles DadswellSVPSell145$205.71$29,827.95View SEC Filing  
9/5/2017Marc StapleyEVPSell2,000$205.93$411,860.0036,179View SEC Filing  
8/31/2017Michel BouchardInsiderSell5,390$202.11$1,089,372.9015,161View SEC Filing  
8/30/2017Michel BouchardCAOSell616$200.00$123,200.0015,161View SEC Filing  
8/29/2017Jay T FlatleyDirectorSell22,540$195.21$4,400,033.40539,176View SEC Filing  
8/28/2017Jay T FlatleyDirectorSell2,540$197.39$501,370.60539,176View SEC Filing  
8/15/2017Jay T FlatleyDirectorSell20,000$194.73$3,894,600.00539,176View SEC Filing  
8/7/2017Omead OstadanEVPSell1,671$195.26$326,279.4624,571View SEC Filing  
8/3/2017Charles DadswellSVPSell1,609$197.00$316,973.009,037View SEC Filing  
8/3/2017Marc StapleyEVPSell2,000$196.80$393,600.0037,941View SEC Filing  
8/2/2017Jay T FlatleyDirectorSell20,000$176.43$3,528,600.00534,176View SEC Filing  
8/2/2017Michel BouchardInsiderSell3,131$194.97$610,451.0715,777View SEC Filing  
8/2/2017Mostafa RonaghiSVPSell10,000$195.00$1,950,000.0076,585View SEC Filing  
7/18/2017Jay T FlatleyDirectorSell15,000$170.77$2,561,550.00534,176View SEC Filing  
7/14/2017Marc StapleyEVPSell2,000$173.56$347,120.0039,941View SEC Filing  
7/7/2017Omead OstadanEVPSell1,672$172.73$288,804.5626,242View SEC Filing  
7/5/2017Jay T FlatleyDirectorSell15,000$172.92$2,593,800.00534,176View SEC Filing  
7/3/2017Charles DadswellSVPSell145$174.24$25,264.8010,646View SEC Filing  
6/23/2017Michel BouchardInsiderSell246$185.00$45,510.0018,893View SEC Filing  
6/22/2017Jay T FlatleyDirectorSell20,000$178.21$3,564,200.00534,176View SEC Filing  
6/12/2017Marc StapleyEVPSell2,000$170.85$341,700.0041,341View SEC Filing  
6/8/2017Michel BouchardInsiderSell246$178.91$44,011.8619,139View SEC Filing  
6/6/2017Jay T FlatleyDirectorSell20,000$180.24$3,604,800.00539,176View SEC Filing  
6/5/2017Charles DadswellSVPSell145$184.75$26,788.7510,791View SEC Filing  
6/1/2017Jay T FlatleyDirectorSell3,320$180.55$599,426.00519,176View SEC Filing  
5/25/2017Frances ArnoldDirectorSell825$174.77$144,185.258,816View SEC Filing  
5/23/2017Jay T FlatleyDirectorSell15,000$175.53$2,632,950.00534,176View SEC Filing  
5/10/2017A Blaine BowmanDirectorSell2,300$181.61$417,703.0018,004View SEC Filing  
5/9/2017Jay T FlatleyDirectorSell20,000$184.14$3,682,800.00539,176View SEC Filing  
5/9/2017Michel BouchardInsiderSell5,740$184.68$1,060,063.2022,255View SEC Filing  
5/3/2017Charles DadswellSVPSell1,609$187.07$300,995.6310,936View SEC Filing  
4/12/2017A Blaine BowmanDirectorSell3,000$172.72$518,160.0018,704View SEC Filing  
4/7/2017Daniel BradburyDirectorSell600$172.79$103,674.0017,065View SEC Filing  
3/24/2017Omead OstadanEVPSell1,672$170.00$284,240.0029,586View SEC Filing  
3/21/2017Daniel BradburyDirectorSell600$163.56$98,136.0017,065View SEC Filing  
2/17/2017Daniel BradburyDirectorSell600$162.80$97,680.0017,065View SEC Filing  
2/13/2017Omead OstadanEVPSell2,173$163.10$354,416.30View SEC Filing  
2/8/2017A Blaine BowmanDirectorSell3,000$162.74$488,220.0016,204View SEC Filing  
2/6/2017Charles DadswellSVPSell572$161.26$92,240.727,592View SEC Filing  
1/30/2017Omead OstadanEVPSell259$160.90$41,673.1027,949View SEC Filing  
1/19/2017Omead OstadanEVPSell2,378$160.06$380,622.6829,040View SEC Filing  
1/11/2017A Blaine BowmanDirectorSell3,000$162.89$488,670.0018,704View SEC Filing  
1/10/2017Charles DadswellSVPSell116$161.60$18,745.60View SEC Filing  
1/4/2017Daniel BradburyDirectorSell600$135.01$81,006.0017,065View SEC Filing  
12/15/2016Omead OstadanEVPSell2,000$126.16$252,320.00View SEC Filing  
12/12/2016Daniel BradburyDirectorSell600$123.42$74,052.0017,065View SEC Filing  
12/8/2016Omead OstadanEVPSell3,000$121.63$364,890.0052,988View SEC Filing  
12/1/2016Omead OstadanEVPSell3,000$133.30$399,900.0051,492View SEC Filing  
11/14/2016Daniel BradburyDirectorSell600$136.34$81,804.0017,065View SEC Filing  
10/7/2016Daniel BradburyDirectorSell600$184.36$110,616.0017,065View SEC Filing  
10/4/2016Charles DadswellSVPSell116$182.38$21,156.0839,900View SEC Filing  
9/20/2016Robert S EpsteinDirectorSell300$174.29$52,287.006,924View SEC Filing  
9/15/2016Marc StapleyEVPSell1,270$172.87$219,544.9033,916View SEC Filing  
9/14/2016Daniel BradburyDirectorSell600$171.25$102,750.0017,065View SEC Filing  
8/23/2016Jay T FlatleyDirectorSell20,000$172.99$3,459,800.00508,061View SEC Filing  
8/22/2016Robert S EpsteinDirectorSell300$170.27$51,081.007,224View SEC Filing  
8/17/2016Daniel BradburyDirectorSell600$168.42$101,052.0017,065View SEC Filing  
8/15/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00498,061View SEC Filing  
8/12/2016Roy A WhitfieldDirectorSell4,000$167.22$668,880.006,853View SEC Filing  
8/9/2016Jay T FlatleyDirectorSell10,000$165.97$1,659,700.00498,061View SEC Filing  
8/1/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00498,061View SEC Filing  
7/27/2016Charles DadswellSVPSell8,632$155.00$1,337,960.0040,248View SEC Filing  
7/26/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00498,061View SEC Filing  
7/20/2016Robert S EpsteinDirectorSell1,200$150.00$180,000.007,824View SEC Filing  
7/18/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00498,061View SEC Filing  
7/14/2016A Blaine BowmanDirectorSell5,000$147.14$735,700.0020,704View SEC Filing  
7/11/2016Christian O HenryEVPSell716$141.89$101,593.2418,976View SEC Filing  
6/16/2016A Blaine BowmanDirectorSell5,000$135.08$675,400.0020,704View SEC Filing  
6/15/2016Christian O HenryEVPSell2,141$137.90$295,243.9020,213View SEC Filing  
6/13/2016Roy A WhitfieldDirectorSell3,800$140.44$533,672.006,653View SEC Filing  
6/1/2016Karin EasthamDirectorSell5,000$145.35$726,750.0017,424View SEC Filing  
5/25/2016Christian O HenryEVPSell2,141$144.73$309,866.9322,463View SEC Filing  
5/17/2016Christian O HenryEVPSell2,141$140.84$301,538.4424,174View SEC Filing  
5/12/2016A Blaine BowmanDirectorSell5,000$137.11$685,550.0018,615View SEC Filing  
4/27/2016Christian O HenryEVPSell2,141$138.46$296,442.8627,073View SEC Filing  
4/18/2016Christian O HenryEVPSell2,141$176.01$376,837.4129,889View SEC Filing  
4/18/2016Paul L BianchiVPSell1,884$175.00$329,700.0065,660View SEC Filing  
4/14/2016A Blaine BowmanDirectorSell5,000$172.94$864,700.0018,615View SEC Filing  
4/13/2016Christian O HenryEVPSell12,500$175.00$2,187,500.0042,897View SEC Filing  
4/13/2016Paul L BianchiVPSell6,681$175.00$1,169,175.0067,544View SEC Filing  
4/12/2016Jay T FlatleyCEOSell20,000$170.05$3,401,000.00508,061View SEC Filing  
4/12/2016Roy A WhitfieldDirectorSell4,000$170.00$680,000.005,800View SEC Filing  
4/7/2016David R WaltDirectorSell4,000$168.90$675,600.00635,840View SEC Filing  
4/5/2016Christian O HenryEVPSell2,141$166.07$355,555.8731,997View SEC Filing  
4/4/2016Charles DadswellSVPSell8,382$167.81$1,406,583.4254,970View SEC Filing  
3/23/2016Christian O HenryEVPSell2,141$155.05$331,962.0533,738View SEC Filing  
3/22/2016Jay T FlatleyCEOSell10,000$154.18$1,541,800.00498,061View SEC Filing  
3/21/2016Daniel BradburyDirectorSell1,200$155.63$186,756.0015,576View SEC Filing  
3/21/2016Nicholas NaclerioSVPSell4,520$154.25$697,210.0030,020View SEC Filing  
3/17/2016A Blaine BowmanDirectorSell5,000$145.24$726,200.0018,615View SEC Filing  
3/15/2016David R WaltDirectorSell4,000$149.99$599,960.00635,840View SEC Filing  
3/14/2016Christian O HenryEVPSell5,892$155.91$918,621.7238,529View SEC Filing  
3/8/2016Charles DadswellSVPSell8,382$155.63$1,304,490.6666,507View SEC Filing  
3/8/2016Jay T FlatleyCEOSell10,000$154.49$1,544,900.00500,915View SEC Filing  
3/8/2016Omead OstadanEVPSell4,516$156.09$704,902.4460,576View SEC Filing  
3/7/2016Charles DadswellSVPSell116$155.00$17,980.0066,507View SEC Filing  
2/23/2016Jay T FlatleyCEOSell10,000$152.49$1,524,900.00440,784View SEC Filing  
2/17/2016Daniel BradburyDirectorSell1,700$154.74$263,058.0014,376View SEC Filing  
2/12/2016Roy A. WhitfieldDirectorSell3,750$140.30$526,125.001,800View SEC Filing  
2/1/2016Omead OstadanEVPSell1,108$156.73$173,656.8446,476View SEC Filing  
1/26/2016Jay T. FlatleyCEOSell20,000$171.70$3,434,000.00433,423View SEC Filing  
1/13/2016Jay T. FlatleyCEOSell20,000$168.81$3,376,200.00433,423View SEC Filing  
1/4/2016Daniel BradburyDirectorSell1,700$182.80$310,760.0014,376View SEC Filing  
12/28/2015Charles DadswellSVPSell168$188.63$31,689.8441,830View SEC Filing  
12/22/2015Jay T. FlatleyCEOSell25,000$185.38$4,634,500.00433,423View SEC Filing  
12/14/2015Roy A. WhitfieldDirectorSell3,750$175.07$656,512.5013,648View SEC Filing  
12/11/2015Omead OstadanEVPSell260$179.90$46,774.0048,293View SEC Filing  
12/11/2015Paul L BianchiVPSell197$179.90$35,440.3059,827View SEC Filing  
12/10/2015Daniel BradburyDirectorSell1,700$182.37$310,029.0014,376View SEC Filing  
12/8/2015Jay T. FlatleyCEOSell25,000$177.11$4,427,750.00433,423View SEC Filing  
11/27/2015Robert S EpsteinDirectorSell1,000$185.56$185,560.006,935View SEC Filing  
11/25/2015Jay T. FlatleyCEOSell5,000$180.00$900,000.00423,793View SEC Filing  
11/24/2015Jay T. FlatleyCEOSell20,000$173.27$3,465,400.00423,793View SEC Filing  
11/16/2015Jay T. FlatleyCEOSell10,000$170.00$1,700,000.00423,793View SEC Filing  
11/10/2015Daniel BradburyDirectorSell1,700$154.03$261,851.0014,376View SEC Filing  
11/10/2015Jay T. FlatleyCEOSell10,000$154.58$1,545,800.00423,793View SEC Filing  
11/3/2015Charles DadswellSVPSell158$150.00$23,700.0040,847View SEC Filing  
10/15/2015Jay T. FlatleyCEOSell10,000$150.00$1,500,000.00424,996View SEC Filing  
10/7/2015Daniel BradburyDirectorSell1,700$145.81$247,877.0014,376View SEC Filing  
9/29/2015David R WaltDirectorSell2,000$171.65$343,300.00648,840View SEC Filing  
9/22/2015Jay T. FlatleyCEOSell25,000$192.79$4,819,750.00424,996View SEC Filing  
9/15/2015David R WaltDirectorSell2,000$206.45$412,900.00648,840View SEC Filing  
9/14/2015Daniel BradburyDirectorSell1,700$203.89$346,613.0014,376View SEC Filing  
9/9/2015Paul L. BianchiVPSell1,245$199.32$248,153.4058,519View SEC Filing  
9/8/2015Jay T. FlatleyCEOSell25,000$194.87$4,871,750.00424,996View SEC Filing  
9/8/2015Karin EasthamDirectorSell4,300$195.76$841,768.0010,419View SEC Filing  
9/4/2015Roy A. WhitfieldDirectorSell4,500$192.63$866,835.0013,648View SEC Filing  
9/1/2015David R WaltDirectorSell2,000$195.08$390,160.00648,840View SEC Filing  
8/27/2015Jay T. FlatleyCEOSell25,000$200.16$5,004,000.00424,996View SEC Filing  
8/18/2015David R WaltDirectorSell2,000$206.89$413,780.00View SEC Filing  
8/17/2015Daniel BradburyDirectorSell1,700$208.14$353,838.00View SEC Filing  
8/13/2015Jay T FlatleyCEOSell25,000$207.85$5,196,250.00View SEC Filing  
8/5/2015Roy A. WhitfieldDirectorSell4,500$215.22$968,490.0013,648View SEC Filing  
7/24/2015A Blaine BowmanDirectorSell3,000$221.47$664,410.00View SEC Filing  
7/23/2015Jay T FlatleyCEOSell25,000$214.87$5,371,750.00View SEC Filing  
7/21/2015David R WaltDirectorSell12,000$235.24$2,822,880.00View SEC Filing  
7/17/2015Mostafa RonaghiSVPSell1,200$235.00$282,000.00View SEC Filing  
7/16/2015Christian O HenrySVPSell5,390$229.61$1,237,597.90View SEC Filing  
7/15/2015Mostafa RonaghiSVPSell3,000$227.19$681,570.00View SEC Filing  
7/14/2015David R WaltDirectorSell10,000$227.39$2,273,900.00View SEC Filing  
7/13/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
7/13/2015Michel BouchardCAOSell1,400$222.75$311,850.00View SEC Filing  
7/10/2015Omead OstadanSVPSell1,110$219.81$243,989.10View SEC Filing  
7/10/2015Robert S EpsteinDirectorSell2,000$219.81$439,620.00View SEC Filing  
7/9/2015Jay T FlatleyCEOSell25,000$218.10$5,452,500.00View SEC Filing  
7/7/2015David R WaltDirectorSell10,000$220.22$2,202,200.00View SEC Filing  
7/6/2015Daniel BradburyDirectorSell1,700$219.70$373,490.00View SEC Filing  
6/30/2015David R WaltDirectorSell10,000$217.64$2,176,400.00View SEC Filing  
6/25/2015Jay T FlatleyCEOSell25,000$220.34$5,508,500.00View SEC Filing  
6/24/2015A Blaine BowmanDirectorSell3,000$221.43$664,290.00View SEC Filing  
6/24/2015Christian O HenrySVPSell5,084$221.07$1,123,919.88View SEC Filing  
6/23/2015David R WaltDirectorSell12,000$220.11$2,641,320.00View SEC Filing  
6/17/2015Christian O HenrySVPSell3,751$215.71$809,128.21View SEC Filing  
6/16/2015David R WaltDirectorSell10,000$215.14$2,151,400.00View SEC Filing  
6/15/2015Nicholas NaclerioSVPSell6,590$214.33$1,412,434.70View SEC Filing  
6/15/2015Paul L BianchiVPSell3,408$215.83$735,548.64View SEC Filing  
6/12/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
6/12/2015Michel BouchardCAOSell1,400$216.11$302,554.00View SEC Filing  
6/11/2015Jay T FlatleyCEOSell25,000$216.41$5,410,250.00View SEC Filing  
6/10/2015Christian O HenrySVPSell10,000$214.94$2,149,400.00View SEC Filing  
6/10/2015Robert S EpsteinDirectorSell2,000$214.24$428,480.00View SEC Filing  
6/5/2015Roy A WhitfieldDirectorSell4,500$207.49$933,705.00View SEC Filing  
6/2/2015David R WaltDirectorSell10,000$204.42$2,044,200.00View SEC Filing  
6/1/2015Karin EasthamDirectorSell5,000$205.24$1,026,200.00View SEC Filing  
5/29/2015Daniel BradburyDirectorSell1,700$206.62$351,254.00View SEC Filing  
5/28/2015Jay T FlatleyCEOSell25,000$208.78$5,219,500.00View SEC Filing  
5/22/2015A Blaine BowmanDirectorSell3,000$204.58$613,740.00View SEC Filing  
5/19/2015David R WaltDirectorSell10,000$202.00$2,020,000.00View SEC Filing  
5/14/2015Christian O HenrySVPSell3,751$198.52$744,648.52View SEC Filing  
5/14/2015Jay T FlatleyCEOSell25,000$197.76$4,944,000.00View SEC Filing  
5/13/2015Paul L BianchiVPSell3,356$197.14$661,601.84View SEC Filing  
5/11/2015Robert S EpsteinDirectorSell2,000$196.49$392,980.00View SEC Filing  
4/28/2015David R WaltDirectorSell7,000$183.88$1,287,160.00View SEC Filing  
4/24/2015A Blaine BowmanDirectorSell3,000$190.73$572,190.00View SEC Filing  
4/23/2015Jay T FlatleyCEOSell25,000$189.57$4,739,250.00View SEC Filing  
4/21/2015David R WaltDirectorSell10,000$197.95$1,979,500.00View SEC Filing  
4/15/2015Christian O HenrySVPSell3,751$189.02$709,014.02View SEC Filing  
4/14/2015David R WaltDirectorSell7,000$188.23$1,317,610.00View SEC Filing  
4/13/2015Marc StapleyCFOSell3,000$190.12$570,360.00View SEC Filing  
4/13/2015Michel BouchardCAOSell1,400$188.61$264,054.00View SEC Filing  
4/13/2015Paul L BianchiVPSell3,390$187.22$634,675.80View SEC Filing  
4/10/2015Robert S EpsteinDirectorSell2,000$186.99$373,980.00View SEC Filing  
4/9/2015Jay T FlatleyCEOSell25,000$184.55$4,613,750.00View SEC Filing  
4/8/2015Daniel BradburyDirectorSell1,700$185.32$315,044.00View SEC Filing  
4/7/2015David R WaltDirectorSell5,000$184.28$921,400.00View SEC Filing  
4/6/2015Roy A WhitfieldDirectorSell4,600$181.32$834,072.00View SEC Filing  
3/26/2015Jay T FlatleyCEOSell25,000$181.34$4,533,500.00View SEC Filing  
3/24/2015David R WaltDirectorSell5,000$192.16$960,800.00View SEC Filing  
3/17/2015A Blaine BowmanDirectorSell3,000$192.30$576,900.00View SEC Filing  
3/16/2015Gerald MoellerDirectorSell2,700$193.36$522,072.00View SEC Filing  
3/16/2015Nicholas NaclerioSVPSell6,590$193.94$1,278,064.60View SEC Filing  
3/13/2015Paul L BianchiVPSell3,390$186.67$632,811.30View SEC Filing  
3/12/2015Marc StapleyCFOSell3,314$189.01$626,379.14View SEC Filing  
3/10/2015Richard KlausnerSVPSell1,186$191.75$227,415.50View SEC Filing  
3/10/2015Robert S EpsteinDirectorSell3,000$191.75$575,250.00View SEC Filing  
2/26/2015Jay T FlatleyCEOSell25,000$195.73$4,893,250.00View SEC Filing  
2/12/2015Jay T FlatleyCEOSell25,000$194.64$4,866,000.00View SEC Filing  
2/3/2015David R WaltDirectorSell7,000$190.89$1,336,230.00View SEC Filing  
2/2/2015Karin EasthamDirectorSell10,000$192.77$1,927,700.00View SEC Filing  
2/2/2015Nicholas NaclerioSVPSell15,250$194.37$2,964,142.50View SEC Filing  
1/27/2015Charles DadswellSVPSell224$198.90$44,553.60View SEC Filing  
1/27/2015David R WaltDirectorSell4,000$201.76$807,040.00View SEC Filing  
1/22/2015Jay T FlatleyCEOSell25,000$188.48$4,712,000.00View SEC Filing  
1/20/2015William H RastetterDirectorSell16,000$188.99$3,023,840.00View SEC Filing  
1/15/2015Marc StapleyCFOSell1,422$181.62$258,263.64View SEC Filing  
1/8/2015Jay T FlatleyCEOSell25,000$197.62$4,940,500.00View SEC Filing  
1/6/2015David R WaltDirectorSell6,000$188.55$1,131,300.00View SEC Filing  
1/2/2015Karin EasthamDirectorSell10,000$185.63$1,856,300.00View SEC Filing  
12/30/2014David R WaltDirectorSell5,000$186.95$934,750.00View SEC Filing  
12/29/2014Gerald MoellerDirectorSell8,000$187.05$1,496,400.00View SEC Filing  
12/26/2014Jay T FlatleyCEOSell25,000$186.71$4,667,750.00View SEC Filing  
12/23/2014David R WaltDirectorSell7,000$184.55$1,291,850.00View SEC Filing  
12/16/2014David R WaltDirectorSell5,000$178.35$891,750.00View SEC Filing  
12/15/2014Marc StapleyCFOSell1,422$181.09$257,509.98View SEC Filing  
12/11/2014Jay T FlatleyCEOSell25,000$185.79$4,644,750.00View SEC Filing  
12/9/2014David R WaltDirectorSell7,000$186.75$1,307,250.00View SEC Filing  
12/8/2014Daniel BradburyDirectorSell1,600$190.14$304,224.00View SEC Filing  
12/4/2014Karin EasthamDirectorSell10,000$191.87$1,918,700.00View SEC Filing  
12/1/2014Mostafa RonaghiSVPSell10,000$188.46$1,884,600.00View SEC Filing  
11/26/2014Paul L BianchiSVPSell1,626$189.20$307,639.20View SEC Filing  
11/17/2014Roy A WhitfieldDirectorSell4,000$178.26$713,040.00View SEC Filing  
11/14/2014Marc StapleyCFOSell1,422$181.13$257,566.86View SEC Filing  
11/13/2014Daniel BradburyDirectorSell2,100$186.88$392,448.00View SEC Filing  
11/13/2014Jay T FlatleyCEOSell25,000$189.32$4,733,000.00View SEC Filing  
11/3/2014Michel BouchardCAOSell631$195.68$123,474.08View SEC Filing  
11/3/2014Mostafa RonaghiSVPSell10,000$195.66$1,956,600.00View SEC Filing  
10/30/2014Daniel BradburyDirectorSell2,100$191.83$402,843.00View SEC Filing  
10/23/2014Jay T FlatleyCEOSell25,000$189.54$4,738,500.00View SEC Filing  
10/13/2014Daniel BradburyDirectorSell2,100$152.03$319,263.00View SEC Filing  
10/9/2014Jay T FlatleyCEOSell25,000$163.49$4,087,250.00View SEC Filing  
10/7/2014A Blaine BowmanDirectorSell4,456$159.51$710,776.56View SEC Filing  
10/1/2014Daniel BradburyDirectorSell2,100$158.88$333,648.00View SEC Filing  
10/1/2014Mostafa RonaghiSVPSell10,000$159.81$1,598,100.00View SEC Filing  
9/30/2014A Blaine BowmanDirectorSell5,000$164.02$820,100.00View SEC Filing  
9/29/2014Gerald MoellerDirectorSell5,000$164.89$824,450.00View SEC Filing  
9/25/2014Jay T FlatleyCEOSell25,000$164.43$4,110,750.00View SEC Filing  
9/24/2014Christian O HenrySVPSell20,000$167.28$3,345,600.00View SEC Filing  
9/23/2014A Blaine BowmanDirectorSell5,000$168.50$842,500.00View SEC Filing  
9/16/2014A Blaine BowmanDirectorSell5,000$169.60$848,000.00View SEC Filing  
9/15/2014Daniel BradburyDirectorSell2,100$168.57$353,997.00View SEC Filing  
9/15/2014Jay T FlatleyCEOSell25,000$176.06$4,401,500.00View SEC Filing  
9/15/2014Marc StapleyCFOSell1,422$169.05$240,389.10View SEC Filing  
9/15/2014Nicholas NaclerioSVPSell2,000$169.53$339,060.00View SEC Filing  
9/9/2014A Blaine BowmanDirectorSell5,000$178.08$890,400.00View SEC Filing  
9/3/2014Christian O HenrySVPSell10,000$180.59$1,805,900.00View SEC Filing  
9/3/2014Daniel BradburyDirectorSell2,100$179.77$377,517.00View SEC Filing  
9/2/2014A Blaine BowmanDirectorSell5,000$179.67$898,350.00View SEC Filing  
9/2/2014Michel BouchardVPSell686$180.07$123,528.02View SEC Filing  
9/2/2014Mostafa RonaghiSVPSell10,000$179.66$1,796,600.00View SEC Filing  
8/28/2014Jay T FlatleyCEOSell30,000$178.98$5,369,400.00View SEC Filing  
8/26/2014A Blaine BowmanDirectorSell5,000$179.22$896,100.00View SEC Filing  
8/22/2014Daniel BradburyDirectorSell2,100$172.24$361,704.00View SEC Filing  
8/19/2014A Blaine BowmanDirectorSell5,000$171.70$858,500.00View SEC Filing  
8/15/2014Nicholas NaclerioSVPSell2,000$167.23$334,460.00View SEC Filing  
8/15/2014Roy A WhitfieldDirectorSell4,000$169.28$677,120.00View SEC Filing  
8/13/2014Christian O HenrySVPSell20,000$164.66$3,293,200.00View SEC Filing  
8/5/2014A Blaine BowmanDirectorSell5,000$159.91$799,550.00View SEC Filing  
8/4/2014Daniel BradburyDirectorSell2,100$159.77$335,517.00View SEC Filing  
8/1/2014Mostafa RonaghiSVPSell10,000$159.73$1,597,300.00View SEC Filing  
7/29/2014A Blaine BowmanDirectorSell5,000$166.89$834,450.00View SEC Filing  
7/29/2014Christian O HenrySVPSell10,000$167.40$1,674,000.00View SEC Filing  
7/24/2014Jay T FlatleyCEOSell30,000$175.43$5,262,900.00View SEC Filing  
7/23/2014Daniel BradburyDirectorSell2,100$177.87$373,527.00View SEC Filing  
7/15/2014Nicholas NaclerioSVPSell2,000$174.26$348,520.00View SEC Filing  
7/14/2014Marc StapleyCFOSell1,422$177.59$252,532.98View SEC Filing  
7/10/2014Jay T FlatleyCEOSell30,000$172.56$5,176,800.00View SEC Filing  
7/8/2014Daniel BradburyDirectorSell2,100$172.89$363,069.00View SEC Filing  
7/1/2014Mostafa RonaghiSVPSell10,000$179.47$1,794,700.00View SEC Filing  
6/30/2014Gerald MoellerDirectorSell5,000$178.97$894,850.00View SEC Filing  
6/27/2014Daniel BradburyDirectorSell2,100$171.65$360,465.00View SEC Filing  
6/26/2014Jay T FlatleyCEOSell30,000$170.11$5,103,300.00View SEC Filing  
6/24/2014Christian O HenrySVPSell10,000$172.60$1,726,000.00View SEC Filing  
6/16/2014Christian O HenrySVPSell20,000$169.73$3,394,600.00View SEC Filing  
6/16/2014Marc StapleyCFOSell1,422$169.25$240,673.50View SEC Filing  
6/12/2014Daniel BradburyDirectorSell2,100$171.17$359,457.00View SEC Filing  
6/12/2014Jay T FlatleyCEOSell30,000$172.25$5,167,500.00View SEC Filing  
6/2/2014Karin EasthamDirectorSell6,000$157.56$945,360.00View SEC Filing  
6/2/2014Michel BouchardCAOSell1,491$155.51$231,865.41View SEC Filing  
6/2/2014Mostafa RonaghiSVPSell10,000$156.93$1,569,300.00View SEC Filing  
5/22/2014Jay FlatleyCEOSell30,000$154.95$4,648,500.00381,262View SEC Filing  
5/15/2014Nicholas NaclerioSVPSell2,000$141.72$283,440.0023,146View SEC Filing  
5/15/2014Roy WhitfieldDirectorSell4,000$143.71$574,840.009,196View SEC Filing  
5/14/2014Daniel BradburyDirectorSell2,100$146.46$307,566.009,924View SEC Filing  
5/14/2014Marc StapleyCFOSell1,422$146.94$208,948.6821,996View SEC Filing  
5/8/2014Jay FlatleyCEOSell30,000$143.59$4,307,700.00381,262View SEC Filing  
5/2/2014Daniel BradburyDirectorSell2,100$139.66$293,286.009,924View SEC Filing  
5/1/2014Mostafa RonaghiSVPSell10,000$135.91$1,359,100.0028,604View SEC Filing  
4/24/2014Jay FlatleyCEOSell30,000$150.80$4,524,000.00381,262View SEC Filing  
4/15/2014Daniel BradburyDirectorSell2,100$131.29$275,709.009,924View SEC Filing  
4/15/2014Nicholas NaclerioSVPSell2,000$133.56$267,120.0023,146View SEC Filing  
4/14/2014Marc StapleyCFOSell1,422$134.80$191,685.6021,996View SEC Filing  
4/10/2014Jay FlatleyCEOSell30,000$139.90$4,197,000.00381,262View SEC Filing  
4/4/2014Daniel BradburyDirectorSell2,100$138.44$290,724.009,924View SEC Filing  
4/1/2014Mostafa RonaghiSVPSell10,000$152.41$1,524,100.0028,604View SEC Filing  
3/27/2014Jay FlatleyCEOSell30,000$140.11$4,203,300.00381,262View SEC Filing  
3/19/2014Daniel BradburyDirectorSell2,100$161.14$338,394.009,924View SEC Filing  
3/17/2014Gerald MoellerDirectorSell10,000$161.92$1,619,200.0014,620View SEC Filing  
3/17/2014Nicholas NaclerioSVPSell2,000$163.65$327,300.0023,146View SEC Filing  
3/14/2014Marc StapleyCFOSell1,422$163.35$232,283.7021,996View SEC Filing  
3/13/2014Jay FlatleyCEOSell30,000$165.96$4,978,800.00381,262View SEC Filing  
3/11/2014Christian HenrySVPSell3,000$167.16$501,480.0028,519View SEC Filing  
3/11/2014Michel BouchardCAOSell2,168$167.21$362,511.2825,049View SEC Filing  
3/3/2014Michel BouchardCAOSell2,994$176.81$529,369.1429,580View SEC Filing  
2/25/2014Michel BouchardCAOSell24,505$176.13$4,316,065.6529,580View SEC Filing  
2/24/2014Roy WhitfieldDirectorSell2,000$175.26$350,520.009,196View SEC Filing  
2/18/2014Nicholas NaclerioSVPSell2,000$169.77$339,540.0025,781View SEC Filing  
2/13/2014Jay FlatleyCEOSell30,000$160.43$4,812,900.00385,105View SEC Filing  
2/7/2014Jay FlatleyCEOSell5,000$152.23$761,150.00398,105View SEC Filing  
1/31/2014Marc StapleyCFOSell20,038$151.32$3,032,150.1621,797View SEC Filing  
1/23/2014Jay FlatleyCEOSell30,000$142.30$4,269,000.00399,509View SEC Filing  
1/9/2014Jay FlatleyCEOSell30,000$114.77$3,443,100.00399,509View SEC Filing  
12/26/2013Jay FlatleyCEOSell30,000$107.88$3,236,400.00399,509View SEC Filing  
12/17/2013Gregory HeathSVPSell1,875$102.68$192,525.0026,740View SEC Filing  
10/30/2013Christian O HenrySVPSell6,000$93.29$559,740.00View SEC Filing  
10/30/2013David R WaltDirectorSell5,000$93.02$465,100.00View SEC Filing  
10/28/2013William H RastetterDirectorSell20,000$92.37$1,847,400.00View SEC Filing  
10/24/2013Jay T FlatleyCEOSell30,000$92.32$2,769,600.00View SEC Filing  
10/22/2013Nicholas NaclerioSVPSell20,000$90.00$1,800,000.00View SEC Filing  
10/17/2013Gregory HeathSVPSell1,875$82.09$153,918.75View SEC Filing  
10/16/2013David R WaltDirectorSell5,000$82.59$412,950.00View SEC Filing  
10/15/2013Nicholas NaclerioSVPSell4,000$81.32$325,280.00View SEC Filing  
10/10/2013Christian HenrySVPSell6,000$77.73$466,380.0030,236View SEC Filing  
10/10/2013Jay FlatleyCEOSell20,000$77.75$1,555,000.00399,509View SEC Filing  
10/2/2013David R WaltDirectorSell5,000$80.58$402,900.00View SEC Filing  
9/18/2013David WaltDirectorSell5,000$83.11$415,550.00926,488View SEC Filing  
9/17/2013Gregory HeathSVPSell1,875$85.20$159,750.0026,740View SEC Filing  
9/16/2013Jay FlatleyCEOSell30,000$83.27$2,498,100.00399,509View SEC Filing  
9/16/2013Nicholas NaclerioSVPSell4,000$85.00$340,000.0024,559View SEC Filing  
9/10/2013Gregory HeathSVPSell1,875$82.00$153,750.00View SEC Filing  
9/9/2013Paul L BianchiSVPSell1,627$79.03$128,581.81View SEC Filing  
9/5/2013Christian O HenrySVPSell9,000$78.17$703,530.00View SEC Filing  
9/4/2013David R WaltDirectorSell5,000$77.18$385,900.00View SEC Filing  
9/3/2013Nicholas NaclerioSVPSell59,000$76.91$4,537,690.00View SEC Filing  
9/3/2013Roy A WhitfieldDirectorSell2,000$78.49$156,980.00View SEC Filing  
8/30/2013Mark LewisSVPSell5,000$78.12$390,600.0044,837View SEC Filing  
8/22/2013Jay FlatleyCEOSell20,000$78.65$1,573,000.00399,509View SEC Filing  
8/21/2013David WaltDirectorSell5,000$78.34$391,700.00936,488View SEC Filing  
8/15/2013Nicholas NaclerioSVPSell2,000$78.43$156,860.0024,559View SEC Filing  
8/8/2013Jay FlatleyCEOSell20,000$78.07$1,561,400.00399,509View SEC Filing  
8/7/2013David WaltDirectorSell5,000$78.29$391,450.00941,488View SEC Filing  
8/2/2013Michel BouchardVPSell11,465$80.64$924,537.60View SEC Filing  
7/25/2013Christian O HenrySVPSell11,462$80.89$927,161.18View SEC Filing  
7/25/2013Jay T FlatleyCEOSell20,000$81.01$1,620,200.00View SEC Filing  
7/24/2013David R WaltDirectorSell4,600$81.44$374,624.00View SEC Filing  
7/24/2013Gregory HeathSVPSell209,533$82.00$17,181,706.00View SEC Filing  
7/24/2013Michel BouchardVPSell9,789$79.28$776,071.92View SEC Filing  
7/15/2013Nicholas NaclerioSVPSell2,000$74.50$149,000.00View SEC Filing  
7/11/2013Jay T FlatleyCEOSell20,000$74.90$1,498,000.00View SEC Filing  
7/11/2013Mostafa RonaghiSVPSell24,000$74.95$1,798,800.00View SEC Filing  
7/10/2013David R WaltDirectorSell5,000$74.26$371,300.00View SEC Filing  
7/10/2013Michel BouchardVPSell3,618$74.30$268,817.40View SEC Filing  
7/9/2013Christian O HenrySVPSell9,000$74.01$666,090.00View SEC Filing  
6/27/2013Jay T FlatleyCEOSell20,000$74.96$1,499,200.00View SEC Filing  
6/26/2013David R WaltDirectorSell5,000$75.36$376,800.00View SEC Filing  
6/26/2013Michel BouchardVPSell4,272$75.06$320,656.32View SEC Filing  
6/25/2013Tristan OrpinSVPSell35,000$71.98$2,519,300.00View SEC Filing  
6/17/2013Nicholas NaclerioSVPSell2,000$68.56$137,120.00View SEC Filing  
6/14/2013Christian O HenrySVPSell25,959$68.10$1,767,807.90View SEC Filing  
6/13/2013Jay T FlatleyCEOSell20,000$66.49$1,329,800.00View SEC Filing  
6/13/2013Tristan OrpinSVPSell47,667$66.55$3,172,238.85View SEC Filing  
6/12/2013David R WaltDirectorSell5,000$67.67$338,350.00View SEC Filing  
6/12/2013Michel BouchardVPSell5,170$68.64$354,868.80View SEC Filing  
6/11/2013Mostafa RonaghiSVPSell24,000$69.01$1,656,240.00View SEC Filing  
6/3/2013Karin EasthamDirectorSell10,000$70.34$703,400.00View SEC Filing  
5/31/2013Mark L LewisSVPSell13,000$71.72$932,360.00View SEC Filing  
5/30/2013Matthew L PosardSVPSell2,836$70.80$200,788.80View SEC Filing  
5/29/2013David R WaltDirectorSell5,000$70.92$354,600.00View SEC Filing  
5/29/2013Michel BouchardVPSell6,276$71.02$445,721.52View SEC Filing  
5/21/2013Jay T FlatleyCEOSell24,000$69.39$1,665,360.00View SEC Filing  
5/20/2013Marc StapleyCFOSell2,843$73.38$208,619.34View SEC Filing  
5/15/2013David R WaltDirectorSell5,000$70.73$353,650.00View SEC Filing  
5/15/2013Michel BouchardVPSell14,241$70.71$1,006,981.11View SEC Filing  
5/15/2013Nicholas NaclerioSVPSell2,000$70.72$141,440.00View SEC Filing  
5/13/2013Mostafa RonaghiSVPSell24,000$68.83$1,651,920.00View SEC Filing  
5/10/2013Tristan OrpinSVPSell25,000$69.60$1,740,000.00View SEC Filing  
5/9/2013Jay T FlatleyCEOSell20,000$66.63$1,332,600.00View SEC Filing  
5/7/2013Tristan OrpinSVPSell5,000$65.68$328,400.00View SEC Filing  
4/8/2013Christian CabouSVPSell16,500$55.00$907,500.00View SEC Filing  
4/8/2013Marc StapleyCFOSell9,175$55.00$504,625.00View SEC Filing  
4/8/2013William H RastetterDirectorSell20,000$54.95$1,099,000.00View SEC Filing  
3/11/2013Marc StapleyCFOSell4,468$53.71$239,976.28View SEC Filing  
11/8/2012Jay T FlatleyCEOSell5,000$47.99$239,950.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Illumina (NASDAQ ILMN) News Headlines

Source:
DateHeadline
Critical Analysis: HTG Molecular Diagnostics (HTGM) vs. Illumina (ILMN)Critical Analysis: HTG Molecular Diagnostics (HTGM) vs. Illumina (ILMN)
www.americanbankingnews.com - May 26 at 7:28 PM
Contrasting PerkinElmer (PKI) & Illumina (ILMN)Contrasting PerkinElmer (PKI) & Illumina (ILMN)
www.americanbankingnews.com - May 26 at 11:07 AM
Abbott Presents Positive Study Results for Tendyne DeviceAbbott Presents Positive Study Results for Tendyne Device
finance.yahoo.com - May 25 at 3:46 PM
5 Top Efficient Stocks to Keep on Your Radar5 Top Efficient Stocks to Keep on Your Radar
finance.yahoo.com - May 25 at 3:46 PM
AbbVie's Imbruvica's Phase III Study Meets Primary EndpointAbbVie's Imbruvica's Phase III Study Meets Primary Endpoint
finance.yahoo.com - May 25 at 10:07 AM
Kaskela Law LLC Announces Investigation of Illumina, Inc. on Behalf of StockholdersKaskela Law LLC Announces Investigation of Illumina, Inc. on Behalf of Stockholders
finance.yahoo.com - May 25 at 10:07 AM
FY2018 Earnings Forecast for Illumina Issued By William Blair (ILMN)FY2018 Earnings Forecast for Illumina Issued By William Blair (ILMN)
www.americanbankingnews.com - May 25 at 7:37 AM
Why is Illumina (ILMN) Up 13.5% Since Its Last Earnings Report?Why is Illumina (ILMN) Up 13.5% Since Its Last Earnings Report?
finance.yahoo.com - May 24 at 10:32 AM
Abbott Gets FDA Nod for XIENCE Sierra, To Boost Vascular WingAbbott Gets FDA Nod for XIENCE Sierra, To Boost Vascular Wing
finance.yahoo.com - May 24 at 10:32 AM
Q2 2018 EPS Estimates for Illumina (ILMN) Raised by William BlairQ2 2018 EPS Estimates for Illumina (ILMN) Raised by William Blair
www.americanbankingnews.com - May 24 at 7:56 AM
Dr. Reddy's (RDY) Q4 Earnings Fall, Revenues Decline Y/YDr. Reddy's (RDY) Q4 Earnings Fall, Revenues Decline Y/Y
finance.yahoo.com - May 23 at 3:46 PM
Medtronic (MDT) Q4 Earnings: Can Spine Division Turn Around?Medtronic (MDT) Q4 Earnings: Can Spine Division Turn Around?
finance.yahoo.com - May 23 at 3:46 PM
Illumina (ILMN) Director Sells $269,800.00 in StockIllumina (ILMN) Director Sells $269,800.00 in Stock
www.americanbankingnews.com - May 22 at 7:46 PM
AstraZeneca's Lokelma Gains FDA Nod to Treat HyperkalemiaAstraZeneca's Lokelma Gains FDA Nod to Treat Hyperkalemia
finance.yahoo.com - May 21 at 3:43 PM
Mostafa Ronaghi Sells 10,000 Shares of Illumina (ILMN) StockMostafa Ronaghi Sells 10,000 Shares of Illumina (ILMN) Stock
www.americanbankingnews.com - May 18 at 10:17 PM
5 Things Every Illumina Investor Needs to Know5 Things Every Illumina Investor Needs to Know
finance.yahoo.com - May 18 at 11:45 AM
Form 4 ILLUMINA INC For: May 14 Filed by: deSouza Francis AForm 4 ILLUMINA INC For: May 14 Filed by: deSouza Francis A
www.streetinsider.com - May 17 at 10:36 AM
Illumina (ILMN) Director Jay T. Flatley Sells 1,460 SharesIllumina (ILMN) Director Jay T. Flatley Sells 1,460 Shares
www.americanbankingnews.com - May 16 at 10:31 PM
Illumina (ILMN) CEO Sells $564,123.00 in StockIllumina (ILMN) CEO Sells $564,123.00 in Stock
www.americanbankingnews.com - May 16 at 10:16 PM
Roche's Actemra Gets FDA Nod for Subcutaneous FormulationRoche's Actemra Gets FDA Nod for Subcutaneous Formulation
finance.yahoo.com - May 15 at 3:44 PM
Illumina buys Edico GenomeIllumina buys Edico Genome
seekingalpha.com - May 15 at 11:55 AM
BRIEF-Illumina Acquires Edico Genome To Accelerate Genomic Data AnalysisBRIEF-Illumina Acquires Edico Genome To Accelerate Genomic Data Analysis
www.reuters.com - May 15 at 11:03 AM
Illumina (ILMN) Acquires Edico GenomeIllumina (ILMN) Acquires Edico Genome
www.streetinsider.com - May 15 at 11:03 AM
Illumina (ILMN) Expected to Announce Quarterly Sales of $783.77 MillionIllumina (ILMN) Expected to Announce Quarterly Sales of $783.77 Million
www.americanbankingnews.com - May 15 at 4:40 AM
Illumina (ILMN) Expected to Post Earnings of $1.10 Per ShareIllumina (ILMN) Expected to Post Earnings of $1.10 Per Share
www.americanbankingnews.com - May 13 at 3:19 AM
Should You Be Tempted To Sell Illumina Inc (NASDAQ:ILMN) At Its Current PE Ratio?Should You Be Tempted To Sell Illumina Inc (NASDAQ:ILMN) At Its Current PE Ratio?
finance.yahoo.com - May 10 at 10:39 AM
5 Winning Stocks With Superb Efficiency Level5 Winning Stocks With Superb Efficiency Level
finance.yahoo.com - May 10 at 10:39 AM
Luna DNA Raises $4 Million Including Key Investors Illumina Ventures and Arch Venture PartnersLuna DNA Raises $4 Million Including Key Investors Illumina Ventures and Arch Venture Partners
www.prnewswire.com - May 8 at 3:43 PM
Todays Research Reports on Trending Tickers: Sorrento Therapeutics and IlluminaToday's Research Reports on Trending Tickers: Sorrento Therapeutics and Illumina
finance.yahoo.com - May 8 at 10:13 AM
Illumina (ILMN) Receives Average Rating of "Buy" from AnalystsIllumina (ILMN) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - May 7 at 3:36 PM
Illumina Stock Upgraded: What You Need to KnowIllumina Stock Upgraded: What You Need to Know
www.fool.com - May 7 at 2:31 PM
Illumina (ILMN) Rating Increased to Overweight at BarclaysIllumina (ILMN) Rating Increased to Overweight at Barclays
www.americanbankingnews.com - May 7 at 1:15 PM
Illumina (ILMN) EVP Sells $318,776.40 in StockIllumina (ILMN) EVP Sells $318,776.40 in Stock
www.americanbankingnews.com - May 4 at 7:52 PM
Illumina (ILMN) Director A Blaine Bowman Sells 3,000 SharesIllumina (ILMN) Director A Blaine Bowman Sells 3,000 Shares
www.americanbankingnews.com - May 3 at 7:52 PM
Leerink Swann Comments on Illuminas Q2 2018 Earnings (ILMN)Leerink Swann Comments on Illumina's Q2 2018 Earnings (ILMN)
www.americanbankingnews.com - April 30 at 1:54 AM
EQUITY ALERT: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties By Management of Illumina ...EQUITY ALERT: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties By Management of Illumina ...
www.businesswire.com - April 29 at 10:29 AM
Q3 2019 EPS Estimates for Illumina Raised by Analyst (ILMN)Q3 2019 EPS Estimates for Illumina Raised by Analyst (ILMN)
www.americanbankingnews.com - April 27 at 10:24 AM
Illumina (ILMN) Expected to Earn Q3 2018 Earnings of $1.12 Per ShareIllumina (ILMN) Expected to Earn Q3 2018 Earnings of $1.12 Per Share
www.americanbankingnews.com - April 27 at 8:50 AM
Zacks: Analysts Expect Illumina (ILMN) Will Announce Quarterly Sales of $770.42 MillionZacks: Analysts Expect Illumina (ILMN) Will Announce Quarterly Sales of $770.42 Million
www.americanbankingnews.com - April 27 at 2:38 AM
Illumina (ILMN) Downgraded by ValuEngine to "Hold"Illumina (ILMN) Downgraded by ValuEngine to "Hold"
www.americanbankingnews.com - April 26 at 2:04 PM
FY2018 EPS Estimates for Illumina (ILMN) Boosted by AnalystFY2018 EPS Estimates for Illumina (ILMN) Boosted by Analyst
www.americanbankingnews.com - April 26 at 10:22 AM
Q2 2018 EPS Estimates for Illumina Boosted by Analyst (ILMN)Q2 2018 EPS Estimates for Illumina Boosted by Analyst (ILMN)
www.americanbankingnews.com - April 26 at 9:06 AM
$1.10 EPS Expected for Illumina (ILMN) This Quarter$1.10 EPS Expected for Illumina (ILMN) This Quarter
www.americanbankingnews.com - April 25 at 5:14 PM
Illumina (ILMN) Q1 2018 Earnings Conference Call TranscriptIllumina (ILMN) Q1 2018 Earnings Conference Call Transcript
www.fool.com - April 25 at 4:10 PM
Illumina (ILMN) Beats on Q1 Earnings, Lifts 18 GuidanceIllumina (ILMN) Beats on Q1 Earnings, Lifts '18 Guidance
www.nasdaq.com - April 25 at 3:43 PM
Illumina Inc. First-Quarter Results: NovaSeq Still the Gift That Keeps on GivingIllumina Inc. First-Quarter Results: NovaSeq Still the Gift That Keeps on Giving
www.fool.com - April 25 at 3:43 PM
Illumina (ILMN) Beats on Q1 Earnings, Lifts '18 GuidanceIllumina (ILMN) Beats on Q1 Earnings, Lifts '18 Guidance
finance.yahoo.com - April 25 at 3:43 PM
Illuminas (ILMN) Hold Rating Reiterated at BarclaysIllumina's (ILMN) Hold Rating Reiterated at Barclays
www.americanbankingnews.com - April 25 at 1:30 PM
Illumina (ILMN) Price Target Raised to $180.00Illumina (ILMN) Price Target Raised to $180.00
www.americanbankingnews.com - April 25 at 11:07 AM
Illumina Inc. Q1 adjusted earnings Beat EstimatesIllumina Inc. Q1 adjusted earnings Beat Estimates
www.nasdaq.com - April 25 at 10:50 AM

SEC Filings

Illumina (NASDAQ:ILMN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Illumina (NASDAQ:ILMN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Illumina (NASDAQ ILMN) Stock Chart for Monday, May, 28, 2018

Loading chart…

This page was last updated on 5/28/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.